Edition:
India

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

3.35USD
1:30am IST
Change (% chg)

$-0.14 (-4.01%)
Prev Close
$3.49
Open
$3.46
Day's High
$3.47
Day's Low
$3.33
Volume
36,272
Avg. Vol
73,964
52-wk High
$14.52
52-wk Low
$3.20

About

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. The Company has developed a platform that enables it to identify cancer targets, find and genetically engineer TCR,... (more)

Overall

Beta: --
Market Cap(Mil.): $763.12
Shares Outstanding(Mil.): 93.52
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates